At a glance

Expression line / wrinkle reduction
Facial muscle relaxation (non-invasive)
Collagen & skin elasticity support
Skin irritation / sensitisation risk
Efficacy uncertainty (limited independent data)
BenefitSide effectHealth risk· more & brighter bars = stronger

Effects

  • Dynamic wrinkle reduction: Clinical in-vivo studies using a 10% topical cream report up to ~63% reduction in wrinkle depth around the eyes over 28 days of twice-daily use; average reductions across participants are typically in the 30–35% range [3][6].
  • Facial muscle relaxation: Reduces the intensity of repetitive micro-muscle contractions (crow's feet, forehead lines, glabellar frown lines) without causing paralysis or a frozen appearance [4][5].
  • Skin surface smoothing: Consistent use progressively softens skin texture and diminishes the visible depth of expression lines [2].
  • Fibroblast & collagen support: Secondary evidence suggests Snap-8 may stimulate fibroblast activity, supporting collagen production, improved hydration, and elasticity beyond its primary muscle-relaxing role [7].
  • Enhanced Argireline efficacy: As an extended 8-amino-acid analog of Argireline (Acetyl Hexapeptide-3), Snap-8 is reported to be approximately 30% more active than its parent peptide in competitive inhibition of SNAP-25 [6].
Classification

Synthetic cosmeceutical neuropeptide / SNARE complex modulator

Route

Topical only (serum, cream, gel)

Working concentration

3–10% in final formulation; clinical studies used 10%

Regulatory status

OTC cosmetic ingredient (not FDA-approved drug); EU & US cosmetic regulations apply

Onset / timeline

Gradual — visible results typically after 4–8 weeks of consistent twice-daily use